We are live on ! Find out more
AGA

Altrinsic Global Advisors Portfolio holdings

AUM $2.79B
1-Year Est. Return 7.25%
This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+7.25%
3 Year Est. Return
+44.27%
5 Year Est. Return
+55.25%
10 Year Est. Return
+173.46%
AUM
$2.48B
AUM Growth
-$131M
Cap. Flow
-$108M
Cap. Flow %
-4.36%
Top 10 Hldgs %
52.06%
Holding
86
New
4
Increased
24
Reduced
34
Closed
4

Top Sells

Rank Stock Value
1
XL
XL Group Ltd.
XL
+$63.3M
2
IBN icon
ICICI Bank
IBN
+$60.5M
3
CSCO icon
Cisco
CSCO
+$14.4M
4
VOD icon
Vodafone
VOD
+$10.9M
5
CB icon
Chubb
CB
+$8.53M

Sector Composition

Rank Sector Weight
1 Financials 30.89%
2 Communication Services 15.11%
3 Healthcare 12.26%
4 Technology 10.72%
5 Industrials 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SABR icon
26
Sabre
SABR
$716M
$31.6M 1.28%
1,473,991
-14,745
-1% -$316K
PEG icon
27
Public Service Enterprise Group
PEG
$38.7B
$30.1M 1.21%
598,532
-5,326
-0.9% -$261K
EBAY icon
28
eBay
EBAY
$51.2B
$28.7M 1.16%
713,629
-6,604
-0.9% -$273K
QCOM icon
29
Qualcomm
QCOM
$164B
$28.5M 1.15%
514,030
+60,255
+13% +$3.84M
EXC icon
30
Exelon
EXC
$48.1B
$26.3M 1.06%
946,535
-8,779
-0.9% -$237K
BP icon
31
BP
BP
$112B
$24.3M 0.98%
644,524
-16,846
-3% -$635K
VZ icon
32
Verizon
VZ
$197B
$23.8M 0.96%
498,497
+6,852
+1% +$344K
ICPT
33
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$23.1M 0.93%
375,223
+64,923
+21% +$3.91M
CTRA
34
DELISTED
Coterra Energy
CTRA
$20M 0.81%
832,419
-7,109
-0.8% -$183K
IONS icon
35
Ionis Pharmaceuticals
IONS
$8.93B
$19.5M 0.79%
442,125
-22,435
-5% -$1.14M
EOG icon
36
EOG Resources
EOG
$77.7B
$19.1M 0.77%
181,659
-1,410
-0.8% -$152K
BIIB icon
37
Biogen
BIIB
$30.9B
$18.1M 0.73%
66,142
-25,979
-28% -$8.06M
TRVG
38
trivago
TRVG
$385M
$17.3M 0.7%
497,305
-11,537
-2% -$454K
BKR icon
39
Baker Hughes
BKR
$58.3B
$16.5M 0.67%
594,042
-6,957
-1% -$213K
APA icon
40
APA Corp
APA
$13B
$15.9M 0.64%
413,874
-133,611
-24% -$5.38M
CSCO icon
41
Cisco
CSCO
$443B
$13.1M 0.53%
304,535
-339,406
-53% -$14.4M
AAC
42
DELISTED
AAC Holdings
AAC
$9.35M 0.38%
814,370
ALXN
43
DELISTED
Alexion Pharmaceuticals
ALXN
$5.57M 0.23%
50,000
+5,000
+11% +$598K
SPNE
44
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$5.53M 0.22%
545,201
MMSI icon
45
Merit Medical Systems
MMSI
$4.82B
$5.44M 0.22%
120,000
PRGO icon
46
Perrigo
PRGO
$1.44B
$5.17M 0.21%
62,000
-4,000
-6% -$349K
AKCA
47
DELISTED
Akcea Therapeutics Inc
AKCA
$4.81M 0.19%
187,800
+37,800
+25% +$814K
BMRN icon
48
BioMarin Pharmaceuticals
BMRN
$11.9B
$4.55M 0.18%
56,168
NXTM
49
DELISTED
NxStage Medical Inc.
NXTM
$4.38M 0.18%
176,300
ELGX
50
DELISTED
Endologix Inc
ELGX
$4.38M 0.18%
103,500
+9,000
+10% +$387K

Similar funds

Altrinsic Global Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Altrinsic Global Advisors held 86 positions worth $2.48B, down 5% from $2.61B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Altrinsic Global Advisors withdrew a net $108M in Q1 2018, closing 4 positions and reducing 34 holdings. Its most notable exit was Kindred Healthcare, an estimated $2.78M position sold in full.

By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 33% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Altrinsic Global Advisors opened a new position in Regenxbio worth $1.79M.

  • Altrinsic Global Advisors's largest Q1 2018 buy was Regenxbio: 60,000 shares worth $1.79M.
  • Altrinsic Global Advisors added most to Check Point Software Technologies in Q1 2018, an estimated $35.1M increase.
  • Altrinsic Global Advisors's biggest Q1 2018 reduction was XL Group Ltd., cutting an estimated $63.3M.
  • Altrinsic Global Advisors fully exited Kindred Healthcare in Q1 2018, selling an estimated $2.78M.
  • Altrinsic Global Advisors's ten largest holdings make up 52% of its $2.48B portfolio in Q1 2018.
  • Altrinsic Global Advisors opened 4 new positions and closed 4 in Q1 2018.
  • Altrinsic Global Advisors's portfolio value fell 5% quarter-over-quarter to $2.48B.

Based on Altrinsic Global Advisors's 13F filing for Q1 2018, filed 14 May 2018.